MedTrace Logo

Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements

NCT05299229 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2022-08-12

No results posted yet for this study

Summary

The purpose of this study is to compare the feasibility and accuracy of two methods of non-invasive hemodynamic assessments - bioreactance as assessed by non-invasive cardiac output monitoring (NICOM; Cheetah Medical) and pulse wave analysis as assessed by finger cuff arterial pressure (ClearSite, Edwards Life Sciences) - compared to hemodynamic assessments by intermittent echocardiography in early onset preeclampsia.

Conditions

  • Pre-Eclampsia

Interventions

DIAGNOSTIC_TEST

Echocardiogrpahy and non-invasive monitoring

Study participants will have echocardiography and non-invasive monitoring by chest/back sensors and a finger cuff.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-29
Primary Completion
2021-12-31
Completion
2021-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05299229 on ClinicalTrials.gov